During the past decade, Virginia Cancer Institute conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Virginia Cancer Institute" #1 collaborator was "Astellas Pharma Inc" with 3 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 2 trials as a collaborator and "Medivation, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Virginia Cancer Institute" are "Advanced, Androgen Receptor Positive Triple Negative Breast Cancer" (1 trials), "Breast Cancer" (1 trials), "Castration-Resistant Prostate Cancer" (1 trials) and "Pancreatic Ductal Carcinoma" (1 trials). Many other conditions were trialed in "Virginia Cancer Institute" in a lesser frequency.

Most popular intervention types in "Virginia Cancer Institute" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Enzalutamide" (3 trials), "Placebo" (2 trials), "Biological: PEGylated Recombinant Human Hyaluronidase (PEGPH20)" (1 trials), "Gemcitabine" (1 trials) and "Placebo (for enzalutamide)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Virginia Cancer Institute" are 2 trials for "Female" genders, 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Virginia Cancer Institute". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Virginia Cancer Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Virginia Cancer Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".